ARCHIVES

Radiotherapy Plus Cetuximab May Control Head/Neck Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Treatment Doesn’t Always Follow Recommendations

February 25, 2005

Anil Potti Explains: “Coming from India, I Did Not Know This Was Not The Real Rhodes Scholarship”

December 16, 2011

NCI Advisors Approve Continuation Of Cancer Genome Atlas Network.

December 19, 2008

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998